We help diagnostics companies and researchers turn lateral flow assays into commercially ready products — from nanoparticle conjugation and strip design through to clinical validation and regulatory compliance.
Wet lab chemistries often show promising results early on. The real challenge shows up during translation onto lateral flow strips tested in the real world — as inconsistent performance, stability issues, failed validation, or missing standards compliance. We provide support at any stage of this process.
Within our team, we have direct experience developing lateral flow assays for different biological fluids designed to meet IVD regulatory compliance, and preparing for independent evaluation. We have also developed point-of-care lateral flow assays for infectious diseases, taking them from early-stage research in academic labs through to commercially viable products in clinical trials.
Whether you're in academia or industry, our end goal is the same — to make a lateral flow strip that works.
Our work covers the full development cycle — from nanoparticle conjugation and strip design through to optimisation, clinical validation, and preparation for standards-based testing. We are not a referral service; when we take on a project, we do the work.
Who we work with
Every service is delivered from a single point of accountability — the same expertise that designs your conjugation system also supports your clinical trial and prepares your regulatory documentation.
One of the most costly mistakes in LFA development is applying the wrong quality framework from the start. Getting this right shapes everything — your facility, your documentation, your clinical program, and your timeline.
Engagements are scoped to the problem — from focused technical sprints to longer advisory retainers. Remote and on-site arrangements are both available; location is not a constraint.
Most development failures aren't random. They follow predictable patterns. Here's what we see most often, and how to get unstuck.
Most assay problems are diagnosable.
The key is systematic elimination — starting with the most likely root cause and working outward. If your strip isn't performing and you're not sure why, a one-hour diagnostic conversation usually identifies the problem.
Whether you're an academic with a promising LFA technology wondering what it takes to get to market, or a diagnostics company finding that real-world performance isn't matching lab results — we'd like to hear from you.